Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

[Metabolic Syndrome as a marker of cardiovascular events in hypertensives in primary prevention].

Costa JA, Rodilla E, Cardona J, González C, Pascual JM.

Med Clin (Barc). 2012 Jul 7;139(4):150-6. doi: 10.1016/j.medcli.2011.05.018. Epub 2011 Aug 2. Spanish.

PMID:
21813141
2.

Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Cutaneous Lupus Erythematosus: A Population-Based Cohort Study.

Singh AG, Crowson CS, Singh S, Denis M, Davis P, Maradit-Kremers H, Matteson EL, Chowdhary VR.

Arthritis Care Res (Hoboken). 2016 Nov;68(11):1664-1670. doi: 10.1002/acr.22892.

3.

Atherosclerotic plaque characteristics are not associated with future cardiovascular events in patients undergoing iliofemoral endarterectomy.

van Haelst STW, Haitjema S, Derksen W, van Koeverden I, de Vries JPM, Moll FL, den Ruijter HM, Pasterkamp G, de Borst GJ.

J Vasc Surg. 2018 Mar;67(3):809-816.e1. doi: 10.1016/j.jvs.2017.07.112. Epub 2017 Oct 7.

PMID:
29017805
4.

Anticoagulant therapy and risk of cerebrovascular events after catheter ablation of atrial fibrillation in the elderly.

Guiot A, Jongnarangsin K, Chugh A, Suwanagool A, Latchamsetty R, Myles JD, Jiang Q, Crawford T, Good E, Pelosi F Jr, Bogun F, Morady F, Oral H.

J Cardiovasc Electrophysiol. 2012 Jan;23(1):36-43. doi: 10.1111/j.1540-8167.2011.02141.x. Epub 2011 Aug 1.

PMID:
21806701
5.

Predictive value of night-time heart rate for cardiovascular events in hypertension. The ABP-International study.

Palatini P, Reboldi G, Beilin LJ, Eguchi K, Imai Y, Kario K, Ohkubo T, Pierdomenico SD, Saladini F, Schwartz JE, Wing L, Verdecchia P.

Int J Cardiol. 2013 Sep 30;168(2):1490-5. doi: 10.1016/j.ijcard.2012.12.103. Epub 2013 Feb 8.

6.

Efficacy of oral nicorandil in patients with end-stage renal disease: a retrospective chart review after coronary angioplasty in Japanese patients receiving hemodialysis.

Ishii H, Toriyama T, Aoyama T, Takahashi H, Yamada S, Kasuga H, Ichimiya S, Kanashiro M, Mitsuhashi H, Maruyama S, Matsuo S, Naruse K, Matsubara T, Murohara T.

Clin Ther. 2007 Jan;29(1):110-22.

PMID:
17379051
7.

Effect of metabolic syndrome on clinical outcomes of non-diabetic peritoneal dialysis patients in India.

Prasad N, Sinha A, Gupta A, Sharma RK, Kaul A, Bhadauria D, Ranagswamy D.

Nephrology (Carlton). 2013 Oct;18(10):657-64. doi: 10.1111/nep.12124.

PMID:
23834643
8.

Prediction of First Cardiovascular Disease Event in Type 1 Diabetes Mellitus: The Steno Type 1 Risk Engine.

Vistisen D, Andersen GS, Hansen CS, Hulman A, Henriksen JE, Bech-Nielsen H, Jørgensen ME.

Circulation. 2016 Mar 15;133(11):1058-66. doi: 10.1161/CIRCULATIONAHA.115.018844. Epub 2016 Feb 17.

PMID:
26888765
9.

[Arterial hypertension and prediabetes].

Boned Ombuena P, Rodilla Sala E, Costa Muñoz JA, Pascual Izuel JM.

Med Clin (Barc). 2016 Nov 4;147(9):387-392. doi: 10.1016/j.medcli.2016.06.032. Epub 2016 Aug 27. Spanish.

PMID:
27575529
10.

Clinical utility of brachial-ankle pulse wave velocity in the prediction of cardiovascular events in diabetic patients.

Katakami N, Osonoi T, Takahara M, Saitou M, Matsuoka TA, Yamasaki Y, Shimomura I.

Cardiovasc Diabetol. 2014 Sep 5;13:128. doi: 10.1186/s12933-014-0128-5.

11.

Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.

Vlek AL, van der Graaf Y, Spiering W, Visseren FL; SMART study group.

J Hum Hypertens. 2008 May;22(5):358-65. doi: 10.1038/jhh.2008.5. Epub 2008 Feb 14.

PMID:
18273039
12.

Trends, predictors, and outcomes of cerebrovascular events related to percutaneous coronary intervention: a 16-year single-center experience.

Hoffman SJ, Holmes DR Jr, Rabinstein AA, Rihal CS, Gersh BJ, Lennon RJ, Bashir R, Gulati R.

JACC Cardiovasc Interv. 2011 Apr;4(4):415-22. doi: 10.1016/j.jcin.2010.11.010.

13.

Early Prediction of Cardiovascular Disease in Kidney Transplant Recipients.

Bilancio G, Celano M, Cozza V, Zingone F, Palladino G, Cirillo M.

Transplant Proc. 2017 Nov;49(9):2092-2098. doi: 10.1016/j.transproceed.2017.09.005.

PMID:
29149967
14.

Incidence of cardiovascular events in which 2 thiazolidinediones are used as add-on treatments for type 2 diabetes mellitus in a Taiwanese population.

Wang CC, Chen WL, Kao TW, Chang YW, Loh CH, Chou CC.

Clin Ther. 2011 Dec;33(12):1904-13. doi: 10.1016/j.clinthera.2011.10.025. Epub 2011 Nov 25. Erratum in: Clin Ther. 2012 Feb;34(2):508. Chou, Chih-Chieh [corrected to Chou, Chin-Chieh].

PMID:
22118894
15.

NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease.

Kohli P, Steg PG, Cannon CP, Smith SC Jr, Eagle KA, Ohman EM, Alberts MJ, Hoffman E, Guo J, Simon T, Sorbets E, Goto S, Bhatt DL; REACH Registry Investigators.

Am J Med. 2014 Jan;127(1):53-60.e1. doi: 10.1016/j.amjmed.2013.08.017. Epub 2013 Nov 23.

PMID:
24280110
16.

Metabolic syndrome: A predictor of adverse outcomes after carotid revascularization.

Protack CD, Bakken AM, Xu J, Saad WA, Lumsden AB, Davies MG.

J Vasc Surg. 2009 May;49(5):1172-80.e1; discussion 1180. doi: 10.1016/j.jvs.2008.12.011.

17.

Cardiovascular and mortality risk of apparent resistant hypertension in women with suspected myocardial ischemia: a report from the NHLBI-sponsored WISE Study.

Smith SM, Huo T, Delia Johnson B, Bittner V, Kelsey SF, Vido Thompson D, Noel Bairey Merz C, Pepine CJ, Cooper-Dehoff RM.

J Am Heart Assoc. 2014 Feb 28;3(1):e000660. doi: 10.1161/JAHA.113.000660.

18.

Influences of age, sex, and LDL-C change on cardiovascular risk reduction with pravastatin treatment in elderly Japanese patients: A post hoc analysis of data from the Pravastatin Anti-atherosclerosis Trial in the Elderly (PATE).

Ouchi Y, Ohashi Y, Ito H, Saito Y, Ishikawa T, Akishita M, Shibata T, Nakamura H, Orimo H; PATE Study Group.

Curr Ther Res Clin Exp. 2006 Jul;67(4):241-56. doi: 10.1016/j.curtheres.2006.08.002.

19.

Prognostic value of ankle brachial index for future incident heart failure in patients without previous heart failure: data from the impressive predictive value of ankle brachial index for clinical long term outcome in patients with cardiovascular disease examined by ABI study.

Nishimura H, Miura T, Minamisawa M, Ueki Y, Abe N, Hashizume N, Mochidome T, Harada M, Shimizu K, Shoin W, Yoshie K, Oguchi Y, Ebisawa S, Motoki H, Izawa A, Koyama J, Ikeda U.

Heart Vessels. 2017 Mar;32(3):295-302. doi: 10.1007/s00380-016-0873-3. Epub 2016 Jul 13.

PMID:
27412398
20.

Long-term prognostic factors after thrombolysis for lower limb ischemia.

Kuoppala M, Franzén S, Lindblad B, Acosta S.

J Vasc Surg. 2008 Jun;47(6):1243-50. doi: 10.1016/j.jvs.2008.01.053.

Supplemental Content

Support Center